首页 | 本学科首页   官方微博 | 高级检索  
     

血清药理法研究补肾化瘀解毒方对肺癌耐药细胞内药物浓度的作用
引用本文:曹勇,张丹,郑广娟,张静. 血清药理法研究补肾化瘀解毒方对肺癌耐药细胞内药物浓度的作用[J]. 中药材, 2003, 26(4): 263-265
作者姓名:曹勇  张丹  郑广娟  张静
作者单位:1. 暨南大学医学院,广州,510632
2. 山东中医药大学肿瘤药理室,济南,250014
基金项目:中国博士后基金(中博基[2000]5号)
摘    要:为了探讨补肾化瘀解毒方对肺癌耐药细胞内Rh123浓度的作用,选择人肺腺癌A549/DDP耐药细胞株为模型,采用荷瘤动物血清药理及流式细胞法,并与正常动物药物血清为对照,结果补肾化瘀解毒方荷瘤动物药物血清能显著提高肺癌A549/DDP耐药细胞内Rh123浓度(P<0.05),与正常动物药物血清无显著性差异(P>0.05),表明补肾化瘀解毒方药物血清能提高肺癌耐药细胞内药物浓度作用。

关 键 词:血清药理法 研究 肺癌 耐药细胞 补肾化瘀解毒方 流式细胞法
修稿时间:2002-12-18

Study on Effect of Drug Concentration of "Bushen huayu jiedu fang" Drug Serum on Drug-Resistance Lung Cancer Cells with Serum Pharmacology
Cao Yong,Zhang Dan,Zheng Guangjuan,Zhang Jing. Study on Effect of Drug Concentration of "Bushen huayu jiedu fang" Drug Serum on Drug-Resistance Lung Cancer Cells with Serum Pharmacology[J]. Journal of Chinese medicinal materials, 2003, 26(4): 263-265
Authors:Cao Yong  Zhang Dan  Zheng Guangjuan  Zhang Jing
Affiliation:Medical School, Jinan University, Guangzhou 510632.
Abstract:To explore RH123 ion concentration effect of "Bushen huayu jiedu fang" (BSHYJD) on drug-resistance lung cancer cells, tumor-bearing animal drug-serum pharmacology and flow cytometry method were utilitied. In contrast with normal animal drug serum, BSHYJD drug-serum of tumor-bearing animal would markedly increase Rh123 concentration in drug-resistance lung cancer cells(P <0. 05) ,but which hasn' t marked discrepancy in contrast with normal animal drug-serum (P >0. 05) ,that indicated BSHYJD drug-serum has inceased drug concentration in drug-resistance lung cancer cells.
Keywords:Bushen huayu jiedu fang"  ,Serum pharmocology,Flow cytometry
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号